Italiano Farmacia on line: comprare cialis senza ricetta, acquistare viagra internet.

Microsoft word - kcc pubs 2004-2006.doc

Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
The members of the GU Multidisciplinary Cancer Clinic of the Kimmel Cancer
Center are leaders in the field of urologic oncology. A listing of some of their
contributions to the field are listed below and includes areas such as scientific
publications, books, book chapters and presentations.

Adam Dicker, MD
1. Adam P. Dicker-Editor-in-Chief, Gregory Merrick, Frank M. Waterman, Richard
Valicenti and Leonard Gomella. Basic and Advanced Techniques in ProstateBrachytherapy. Taylor & Frances Publishers, London UK. ISBN 1841842982Published Jan 2005.
2. Adam P. Dicker, M.D., Ph.D., Christopher Chen, M.D., J. D. Liu, Ph.D, Richard
K. Valicenti, M.D., and Frank M. Waterman, Ph.D. Evaluation of Pubic ArchInterference for Prostate Brachytherapy: Evaluation of Planning PermanentTransperineal Prostate Implants from a “Needles-Eye-View” and Potential forAndrogen Suppression for Reduction of Interference. Basic and AdvancedTechniques in Prostate Brachytherapy. Taylor & Frances Publishers, LondonUK. Published Jan 2005.
3. Lesley Hughes, MD; Frank M. Waterman, PhD.; Adam P. Dicker, MD, PhD.
Salvage of Sub-optimal Prostate Seed Implantation: Re-Implantation of Under-Dosed Region of Prostate Base. Basic and Advanced Techniques in ProstateBrachytherapy. Taylor & Frances Publishers, London UK. Published Jan 2005.
4. Ashish Patel, Frank M. Waterman and Adam P. Dicker. Can prostate
brachytherapy to treat potential extraprostatic disease? Basic and AdvancedTechniques in Prostate Brachytherapy. Taylor & Frances Publishers, LondonUK. Published Jan 2005.
5. Tracy L. McElveen, M.D., Frank M. Waterman, Ph.D., Hayeon Kim, M.S., and Adam P. Dicker M.D., Ph.D. Factors Predicting for Urinary Incontinence
Following Prostate Brachytherapy. Basic and Advanced Techniques in Prostate
Brachytherapy. Taylor & Frances Publishers, London UK. Published Jan 2005.
6. Adam P. Dicker, Gregory Merrick and Leonard G. Gomella. Introduction. Basic
and Advanced Techniques in Prostate Brachytherapy. Taylor & FrancesPublishers, London UK. Published Jan 2005.
7. Kenneth Hu, Louis B. Harrison, Bruce Culliney, Adam P. Dicker and Roy
Sessions. Cancer of the Oropharynx. In: Textbook of Radiation Oncology, 2ndEdition, edited by Steven A. Leibel and Theodore L. Phillips. W. B. SaundersCompany, Philadelphia, Pa. 2004.
8. Deborah Citrin, MD, Kevin Camphausen, MD, Walter Curran, Jr., MD, Adam P.
Dicker, MD, Ph D. Evaluation of Novel Agents as Radiosensitizers from
Laboratory to Clinic. ASCO Educational Book, 2007
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
9. Patterns of Care in Cancer Medicine Management of Prostate Cancer, Editor, 10. Contributing Editors: Adam P. Dicker, MD, PhD and Mark Soloway,
MDResearch to Practice, Miami, FLVol 1, Issue 1, 2005 11. Adam P. Dicker, M.D., Ph.D. Forward: Epidermal growth factor receptor
inhibitors and cancer therapeutics. Int. J. Radiation Oncology Biol. Phys., Vol.
58, No. 3, p. 898, 2004.
12. Adam P. Dicker and Ulrich Rodeck. Targeting the epidermal growth factor
receptor in cancer-rationale for therapeutic ratio. International Journal ofRadiation Oncology, Biology, Physics., Vol. 58, No. 3, p. 899-902, 2004.
13. Adam. P. Dicker, Torian L. Williams, George Iliakis, and Derrick S. Grant.
Targeting Angiogenic Processes by Combination Low Dose Paclitaxel andRadiation Therapy. American Journal of Clinical Oncology; 26(3) e45-53, 2003.
14. Susan Lanza-Jacoby, Adam Dicker, Sheldon Miller, John T. Flynn, Stephanie
Lavorgna, and Randy Burd. COX-2 dependents effects of the cyclooxygenase(COX)-2 inhibitor SC236 when combined with ionizing radiation in mammarytumor cells derived from HER-2/neu mice. Molecular Cancer Therapeutics; April3 (4): 417-424, 2004.
15. Caroline Katzen, B.A., Merrill J. Solan, M.D., and Adam P. Dicker M.D., Ph.D.
E-mail and Oncology: A Survey of Radiation Oncology Patients and theirAttitudes to a New Generation of Health Communication. Prostate Cancer andProstatic Diseases, 2005;8(2):189-93.
16. Tracy L. McElveen, M.D., Frank M. Waterman, Ph. D., Hayeon Kim, M.S., and
Adam P. Dicker M.D., Ph.D. Factors Predicting for Urinary Incontinence
Following Prostate Brachytherapy. International Journal of Radiation Oncology,
Biology, Physics, Volume 59, Issue Number 5, pages 1395-1404, 2004.
17. Gary J. Kelloff, Donald S. Coffey, Bruce A. Chabner, Adam P. Dicker, Kathryn Z.
Guyton, Perry D. Nisen, Howard R. Soule and Anthony V. D’Amico. Prostate-Specific Antigen (Psa) Doubling Time As A Surrogate Marker For Evaluation OfOncologic Drugs To Treat Prostate Cancer. Clinical Cancer Research, Vol. 10,3927–3933, June 1, 2004.
18. George F. Vande Woude1, Raymond W. Ruddon, Han-Mo Koo, Gary J. Kelloff, J. Carl Barrett, Robert W. Day, Adam P. Dicker, Robert S. Kerbel, David R.
Parkinson, William J. Slichenmyer. Reanalysis of approved cancer drugs: old
drugs, new tricks. Clinical Cancer Research, Vol. 10, 3897–3907, June 1, 2004.
19. Phyllis Wachsberger, Ph.D., Randy Burd, Ph.D. and Adam P. Dicker. Improving
Tumor Response to Radiotherapy by Targeting Angiogenesis SignalingPathways. Hematology Oncology Clinics of North America,volume 18, pp 1039-1057, 2004.
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
20. Dietmar W. Siemann, Michael C. Bibby, Graham Dark, Adam P. Dicker, Ferry
A.L.M. Eskens, Michael R. Horsman, Dieter Marmé, and Patricia M. LoRusso.
Differentiation and definition of vascular-targeted therapies. Clinical CancerResearch, 2005 Jan 15;11(2 Pt 1):416-20.
21. Baocheng Hu, Shuang-yin Han, Xiang Wang, Michelle Ottey, Magdalena B.
Potoczek, Adam Dicker, Kay Hubner, and Ya Wang. Involvement of the Fhit
Gene in the Ionizing Radiation-activated ATR/CHK1 Pathway. Journal of Cellular
Physiology
, 2005 Feb;202(2):518-23.
22. McAleer MF, Davidson C, Davidson WR, Yentzer B, Farber SA, Rodeck U, Dicker AP. Novel Use of Zebrafish as a Vertebrate Model to Screen Radiation
Protectors and Sensitizers. International Journal of Radiation Oncology, Biology,
Physics.
Vol 61, No 1, pp 10-13, 2005.
23. Lesley Hughes, Frank M. Waterman, Adam P. Dicker. Salvage of Sub-optimal
Prostate Seed Implantation: Re-Implantation of Under-Dosed Region of ProstateBase. Brachytherapy 4(2) 163-170, 2005.
24. Wendy A Woodward, MD, PhD, Phyllis Wachsberger, PhD, Randy Burd PhD, and Adam P Dicker, MD, PhD. Effects Of Androgen Suppression And Radiation
For Prostate Cancer Suggest A Role For Angiogenesis Blockade. Prostate
Cancer and Prostatic Diseases,
Volume 8, Number 2, 127-132, 2005.
25. Forsberg F, Ro RJ, Potoczek M, Liu JB, Merritt CR, James KM, Dicker AP,
Nazarian LN. Assessment of angiogenesis: implications for ultrasound imaging.
Ultrasonics. 2004 Apr;42(1-9):325-30.
26. P.R. Wachsberger, R. Burd, N. Marrrero, C. Daskalakis A. Ryan, Peter McCue and Adam P Dicker. Effect of the Tumor Vascular Damaging Agent, ZD6126 on
the Radioresponse of U87 Glioblastoma. Clinical Cancer Research, 2005 Jan
15;11(2 Pt 1):835-42.
27. CHK1 Affects Cell Sensitivity to Microtubule-targeted Drugs. Qing Ren, Ronghua Liu, Adam P. Dicker and Ya Wang. Journal of Cellular Physiology, 2005
Apr;203(1):273-6.
28. Adam P. Dicker, MD, PhD and Ulrich Rodeck, MD. Predicting the future, from
trials of the past: EGFR expression and outcome from altered radiation therapyfraction trials. Journal of Clinical Oncology, Vol 23, No 24 (August 20), 2005: pp.
5437-5439
.
29. Kevin T. Duffy, Mary Frances McAleer, William Davidson, Laszlo Kari, Csaba Kari, Chang-Gong Liu, Mest JR, Steven A. Farber, Eric Wickstrom, Keith C.
Cheng, Adam P. Dicker, and Ulrich Rodeck. Coordinate regulation of cell cycle
regulatory genes in zebrafish development: functional consequences of cyclin D1
knockdown with morpholino phosphorodiamidate and hydroxyprolyl-phosphono-
peptide nucleic acids. Nucleic Acids Research, vol 33, Sept. 2005, No. 15, 4914-
4921.

Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
30. Adam P. Dicker, MD, PhD. Foreword: Antiangiogenic Therapy: Maximizing
Therapeutic Gain. International Journal of Radiation Oncology, Biology, Physics.
2006 Jan 1;64(1):14
31. Gabriella Wernicke, M.D., Lawrence Kenyon, M.D., Ph.D., Terry Hyslop, Ph.D., Elizabeth H. Hammond, M.D., Arie Perry, M.D. , David W. Andrews, M.D., Walter
J. Curran, M.D., Jr., and Adam P. Dicker, M.D., Ph.D. Epidermal Growth Factor
Receptor (EGFR) Expression in Human Meningioma. Submitted, Cancer.
32. Qing Ren, Csaba Kari, Marlene R.D. Quadros, Randy Burd, Peter McCue, Adam
P. Dicker and Ulrich Rodeck. Malignant transformation of immortalized HaCaT
keratinocytes through deregulated NF-kB signaling. Cancer Research, 2006
May 15;66(10):5209-15.
33. Phyllis R. Wachsberger, Randy Burd, Tara Strickler, Dianne Rossetti, Nichol Marrrero, Jennifer Workman, Chris Cardi, Mat Thakur, Constantine Daskalakis,
Jocelyn Holash, George D. Yancopoulos, Adam P. Dicker. VEGF Trap
Improves Fractionated Radiotherapy in U87 Glioblastoma: Impact of Scheduling
and Dosing. In press, International Journal of Radiation Oncology, Biology,
Physics
.
34. Mary Frances McAleer, Kevin T. Duffy, William R. Davidson, Gabor Kari, Adam
P. Dicker, Ulrich Rodeck, and Eric Wickstrom. Antisense Inhibition of Cyclin D1
Expression is Equivalent to Flavopiridol for Radiosensitization of Zebrafish
Embryos. International Journal of Radiation Oncology, Biology, Physics, Volume
66, No.2, pp. 546-551, 2006.
35. Kang-Il Kim, MD, PhD, Gregg R. Klein, MD, Joshua Sleeper, BA, Adam Dicker
MD, PhD, Javad Parvizi, MD, FRCS, and Richard H. Rothman, MD, PhD.
Uncemented Total Hip Arthroplasty in Patients with a Prior History of Pelvic
Irradiation for Prostate Cancer. Accepted, Journal of Bone and Joint Surgery
(American)
.
36. Barbori Daroczi, Mary-Frances McAleer, Gabor Kari, Ulrich Rodeck, Adam. P.
Dicker. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in
a zebrafish model, Clinical Cancer Research, Dec 1, 2006, 12: 7086-7091.
37. David K. Gaffney M.D., Ph.D., Kathryn Winter, Adam P Dicker, M.D., Ph.D.,
Brigitte Miller MD, Patricia Eifel, M.D., Janice Ryu, M.D., Vilija Avizonis, M.D.,Mitch Fromm M.D., and Kathryn Greven, M.D. A Phase I-II Study of COX-2Inhibitor, Celebrex (celecoxib) and Chemoradiation in Patients with LocallyAdvanced Cervical Cancer: Primary Endpoint Analysis of RTOG 0128.
International Journal of Radiation Oncology, Biology, Physics, 2007 Jan1;67(1):104-9. 38. William Davidson, Gabor Kari, Mary-Francis McAleer, Csaba Kari, Adam P.
Dicker, Ulrich Rodeck. Off-target effects of the p53 inhibitor Pifithrin-alpha
related to inhibition of p73 in zebrafish embryos. Submitted, Cancer Research.
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
39. Gabor Kari, Ulrich Rodeck and Adam P. Dicker. Zebrafish: An emerging model
system for human disease and drug discovery. Accepted, Clinical Pharmacologyand Therapeutics.
Deborah T. Glassman, MD
1. Kalra P, Glassman DT, Gomella LG, Strup SE, McGinnis DE, Simon DR, Chang MF, Byrne DS, Kuo RL. Outcomes of hand-assisted laparoscopic nephrectomyin technically challenging cases. Urology. 2006 Jan; 67(1):45-9.
2. Merriam, WG, Glassman, DT, Trabulsi,EJ, Gomella, LG. Risk of post-operative
rhabdomyolysis in patients undergoing laparoscopic nephrectomy. 101th AnnualAUA Scientific Meeting. J Urol. 175 (4): 343, April 2006.
3. Chawla, S, Waldman, I, Johannes, J, Byrne, D, Gomella, LG., Glassman, DT. Correlation of Pathology with Tumor Size in a Large Series of Surgically Treatedrenal Masses. Submitted J. Urol.
Presentations and Abstracts
1. Outcomes of Hand Assisted Laparoscopic Nephrectomy in Technically Challenging Cases. Presented at: SUO annual meeting, December 2004.
2. Renal Mass Malignancy is Predicted by Mass Size: An Eight Year Experience.
Presented at: AUA annual meeting, May 2005.
3. Risk of Post-operative Rhabdomyolysis in Patients Undergoing Laparoscopic Nephrectomy. Presented at: AUA annual meeting May, 2006.
4. The Malignant Potential of Small Renal Masses. Presented at: Mid-Atlantic AUA Leonard G. Gomella, MD
Presentations and Abstracts
1. Brown JA*, Chenven E, Gomella, LG, Strup SE and Bagley D. Hand-assisted
laparoscopic nephroureterectomy (HALNU) with en block bladder cuff excision: Efficacy and recurrence rate in 59 consecutive cases. 51st Annual James C.
Kimbrough Urological Seminar, San Antonio, TX, January 2004.
2. Brown JA*, Chenven E, Gomella, LG, Strup SE, Bagley D. Hand-assisted
laparoscopic nephroureterectomy (HALNU) with en bloc bladder cuff excision: Efficacy and recurrence rate in 59 consecutive cases. 68th Annual SESAUA Meeting, Oranjestad, Aruba, March 2004.
3. Halpern EJ, Frauscher F, Strup SE, Ramey JR, Gomella, LG. ROC Analysis of
Contrast Enhanced Ultrasound for the Detection of Prostate Cancer. Journal of Urology 171(suppl):481-482, 2004.(AUA Annual Meeting San Francisco) 4. Management of High Risk Prostate Cancer, Department of Urology Grand Rounds, University of Illinois, Chicago Medical Center Wednesday May 25, 2004 5. Zeltser, I., Gomella, L.G., Grossman, H.B., Fradet, Y., Nseyo, U., Schoenberg, M,
Malkowicz, B., Droller, M., PhotoCure Study. Fluorescence Cystoscopy With Hexvix Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
Improves The Detection Of Bladder Cancer. Mid-Atlantic Annual Meeting Section Of AUA, October 3-6, 2004, Cambridge, Maryland 6. Halpern EJ, Frauscher F, Ramey JR, McCue P, Gomella, LG. Prostate Cancer
Detection with Targeted Biopsy during Contrast-enhanced Sonography.
Proceedings of the 2004 meeting of the RSNA. Pg 268, December 2004.
7. Halpern EJ, Ramey JR, Frauscher F, McCue P,Gomella, LG. Detection of Prostate
Cancer with Contrast-enhanced Sonography Using Harmonic Gray Scale, Color Doppler, and Power Doppler Imaging. Radiology: Proceedings of the 2004 meeting 8. Monami, G., Gonzalez, E.M., Sedor, J., Gomella, L.G., Baffa, R., Iozzo, R.V.,
Morrione, A. Proepithelin Promotes Cell Migration And Invasion Of Bladder Cancer Cells. Society Of Urologic Oncology And The National Cancer Institute, December 9. Glassman, D., Johannes, J., Strup, S., Gomella, L.G., Byrne, D. Renal Mass
Malignancy Is Predicted By Mass Size: An Eight-Year Experience. Society Of Urologic Oncology And The National Cancer Institute, December 3-4, 10. Halpern, E., Ramey, J.R., Frauscher, F., McCue, P., Gomella, L.G. Detection Of
Prostate Cancer With Contrast Enhanced Sonography Using Harmonic Gray Scale, Color Doppler And Power Doppler Imaging. Society Of Urological Oncology And The National Cancer Institute, December 3-4, 2004. Bethesda, MD 11. Kalra, P., Glassman, D., Gomella, L.G., Strup, S., McGinnis, D., Simon, D.S.,
Chang, M., Byrne, D., Kuo, R.L. Outcomes Of Hand Assisted Laparoscopic Nephrectomy (Haln) In Technically Challenging Cases. Society Of Urological Oncology And The National Cancer Institute, December 3-4, 2004. Bethesda, MD 12. Ramey, J.R., Halpern, E., Gomella, L.G. Targeted Biopsy Of The Prostate With
Contrast-Enhanced Transrectal Sonography In Patients With Previous Negative Biopsy. Society Of Urological Oncology And The National Cancer Institute, 13. Halpern, E., Ramey, J.R., Frauscher, F., McCue, P., Gomella L.G. Targeted Biopsy
Of The Prostate During Contrast Enhanced Transrectal Sonography For The Detection Of Prostate Cancer. Multidisciplinary Prostate Cancer Symposium, 14. Ramey, J.R., Halpern, E.J., Gomella, L.G. Prostate Cancer Detection In Patients
With Previous Negative Biopsy Using Contrast-Enhanced Transrectal Sonography And Targeted Biopsies. Multidisciplinary Prostate Cancer Symposium, February 17- 15. Ives, E.P., Burke, M.A., Edmonds, P.R., Gomella, L.G., Halpern, E.J. Quantitative
CT Perfusion Of Prostate Cancer: Correlation With Whole Mount Pathology.
Multidisciplinary Prostate Cancer Symposium, February 17-19, 2005. Orlando, FL 16. Ives, E.P., Gomella, L.G., Halpern, E.J. Impact Of Dutasteride Therapy On Doppler
Evaluation Of The Prostate: Reduced Prostatic Blood Flow And Improved Detection Of Prostate Cancer With Targeted Biopsy. Multidisciplinary Prostate Cancer Symposium, February 17-19, 2005. Orlando, FL 17. Ives, E.P., Burke, M.A., Edmonds, P.R., Gomella, L.G., Halpern, E.J. Preliminary
Experience With Prostate Elastography And Comparison With Biopsy Results.
Multidisciplinary Prostate Cancer Symposium, February 17-19, 2005. Orlando, FL 18. Monami, G., Gonzalez, E., Gomella, L.G., Baffa, R., Iozzo, R.V., Morrione, A.
Proepithelin Promotes Cell Migration And Invasion Of Bladder Cancer Cells.
American Association For Cancer Research, April 16-20, 2005.
19. Ives EP, Gomella, LG, Halpern EJ. Impact of Dutasteride Therapy on Doppler
Evaluation of the Prostate: Reduced Prostatic Blood Flow and Improved Detection of Prostate Cancer with Targeted Biopsy. Proceedings of the 105th Annual Meeting of the American Roentgen Ray Society. AJR 184(4):61, May 2005.
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
20. Ives EP, Waldman I, Gomella, LG, Halpern EJ. Preliminary Experience with Prostate
Elastography and Comparison with Biopsy Results. Proceedings of the 105th Annual Meeting of the American Roentgen Ray Society. AJR 184(4):61, May 2005.
21. Ives EP, Burke MA, Edmonds PR, Gomella, LG, Halpern EJ. Quantitative CT
Perfusion of Prostate Cancer: Correlation with Whole Mount Pathology. Proceedings of the 105th Annual Meeting of the American Roentgen Ray Society. AJR 184(4):61- 22. Ramey, J.R., Halpern, E., Gomella, L.G. Targeted Biopsy Of The Prostate With
Contrast-Enhanced Transrectal Sonography In Patients With Previous Negative Biopsy. American Urological Association Annual Meeting, May 21-26, 2005.San 23. Ives, E., Burke, M., Edmonds, P., Gomella, L.G., Halpern, E. Quantitative CT
Perfusion Of Prostate Cancer: Correlation With Whole Mount Pathology. American Urological Association Annual Meeting, May 21-26, 2005. San Antonio, TX 24. Halpern EJ, Ramey JR, Fruascher F, McCue P, Gomella, LG. Detection of Prostate
Cancer with Contrast Enhanced Sonography Using Harmonic Gray Scale, Color Doppler and Power Doppler Imaging. Proceedings of the AUA abstract #1719, Journal of Urology 173(4):466, 2005. May 21-26, 2005. San Antonio, TX 25. Strup, S., Garret, J.E., Hubosky, S., Shupp-Byrne, D., Gomella, L.G. Hand-Assisted
Laparoscopic Partial Nephrectomy Without Formal Collecting System Closure: Simplified Technique With Solid Results In 76 Patients. American Urological Association Annual Meeting, May 21-26, 2005. San Antonio, TX 26. Gottardo, F., Liu, C.-G., Ferracin, M., Calin, G., Sevignani, C., Shupp-Byrne, D., Negrini, M., Gomella, L., Croce, C.M., Baffa, R. Micro-RNA (miRNAs) Profiling In
Kidney And Bladder Cancers. American Urological Association Annual Meeting, May 27. Johannes, J., Glassman, D., Kallingal, G., Byrne, D., Strup, S., Gomella, L.G. Mass
Size Predicts Probability Of Renal Mass Malignancy. American Urological Association Annual Meeting, May 21-26, 2005. San Antonio, TX 28. Halpern, E., Ramey, J.R., Frauscher, F., McCue, P., Gomella, L.G. Detection Of
Prostatic Cancer With Contrast Enhanced Sonography Using Harmonic Gray Scale, Color Doppler And Power Doppler Imaging. American Urological Association Annual Meeting, May 21-26, 2005. San Antonio, TX 29. *The Challenge of PSA Recurrence, Urology Association of Pennsylvania Annual 30. Targeted Biopsy of the Prostate: Utility of Gray Scale, Color Doppler, and Elastography for the Detection of Prostate Cancer E J Halpern, MD,, C B Slotoroff, MD; E P Ives, MD; I Waldman, MD; M Grogan; L G Gomella, MD RSNA 2005
31. The Cutting Edge: Surgical Options in Prostate Cancer; Gomella, L and McGinnis, D.
Tenth Annual Prostate Cancer Program, American Cancer Society, SE Pennsylvania Chapter, Bala Cynwn, PA September 24, 2005 32. *PSA Recurrence. PCOM Grand Rounds, Philadelphia, PA September 28, 2005 33. *Prostate Cancer Update: 2005. Methodist Hospital Medical Grand Rounds, 34. Nelson, ED., Slotoroff, SB., Gomella, LG., Halpern, EJ. Targeted Biopsy with Color
Doppler and Elastography: A Comparison of Gleason Scores,” The 6th SUO/NCI 35. LeNoir, J, D’Arca, D, Gottardo, F, Bragantini, E, Wildemore, B, Shupp-Byrne, D, Zanesi, N., Croce, CM, Gomella, LG, Baffa, R. Prevention Of Bladder Cancer In
The FHIT Knock-out Mouse Model With Rofecoxib, A COX-2 Inhibitor. The 6th SUO/NCI Winter Meeting December 2-3, 2005.
36. *Prostate Cancer Update: 2006, Kimmel Cancer Center Grand Rounds January 18, 37. *New Approaches to Prostate Cancer: Cincinnati Urologic Society January 16, 2006 Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
38. Mulitmodality Approach to High Risk Prostate Cancer, Department of Urology Grand Rounds, Mt. Sinai Medical Center Baltimore MD April, 2006 39. Pre-treatment with Dutasteride prior to prostate biopsy: Effect on Doppler flow patterns, E J Halpern; P R Gittens; E D Nelson; C B Slotoroff,; E Trabulsi; L G
Gomella, MD Submitted RSNA 2006
40. Monami, G, Gonzalez, EM, Hellman, M, Gomella, LG, Baffa, R, Iozzo,RV, Morrione,
A. A role of proepithelin in tumor invasion: Promotion of cell migration and invasion of bladder cancer cells through the activation of ERK1/2 and the formation of paxillin/FAK/ERK complex. American Association Cancer Research April 6, 2006.
41. Brown, J.J., Garlitz, C.J., Hubosky, S., Gomella, L.G. Hand-assisted laparoscopic
ureterolysis to treat ureteral obstruction secondary to retroperitoneal fibrosis: an assessment of an initial series. 101th Annual AUA Scientific Meeting. J Urol. 175 42. Merriam, W.G., Glassman, D.T., Trabulsi,E.J., Gomella, L.G. Risk of post-operative
rhabdomyolysis in patients undergoing laparoscopic nephrectomy. 101th Annual AUA Scientific Meeting. J Urol. 175 (4): 343, April 2006 Atlanta, GA.
43. Nelson, E.D., Slotoroff, C.B., Waldman, I., Ives, E.P., Gomella, L.G., Halpern, E.J.
Grey scale, color doppler and elastography for the detection of prostate cancer.
101th Annual AUA Scientific Meeting. J Urol. 175 (4): 500, April 2006 Atlanta, GA.
44. Impact of Gray Scale, Color Doppler and Elastography on Prostate Cancer Detection and Gleason Score E J Halpern, MD, E D Nelson; C B Slotoroff, MD; L G Gomella, 45. Halpern EJ, Forsberg F, Gittens PR, Trabulsi EJ and Gomella LG: Microflow
Imaging of the Prostate During Contrast-Enhanced Ultrasound: Initial Experience 46. “Urology Update: Robotic Assisted Laparoscopic Prostatectomy” Eastern Shore Medicine Review, University of Delaware, Rehoboth Beach, DE June 23, 2006 47. *Prostate Cancer Chemoprevention: What To Tell Our Patients”: Kimmel Cancer 48. “Superficial Bladder Cancer 2006 Update”: NE AUA 2006 September 8, 2006 Ottowa 49. “Multimodality Therapy In Prostate Cancer: The Latest Data” George Washington University, Department of Urology Grand Rounds, September 13, 2006 Washington, 50. “Understanding Robotic Prostatectomy”. Nanticoke Regional Medical Center, 51. “The Future of Prostate Cancer” Keynote Address Georgia and South Carolina Urologic Association Annual Meeting, September 28-29, 2006 Sea Island, GA 52. “Bladder Cancer Update” Georgia and South Carolina Urologic Association Annual Meeting, September 28-29, 2006 Sea Island, GA 53. “Open vs Laparoscopic Partial Nephrectomy” Georgia and South Carolina Urologic Association Annual Meeting, September 28-29, 2006 Sea Island, GA 54. Gomella, LG, Nelson ED ; Slotoroff, CB Halpern, EJ “Color Flow, Elastography and
Prostate Cancer Diagnosis” Society of Pelvic Surgeons October 12, 2006 Annual 55. “ Bladder Cancer: Recurrence vs progression” Jefferson Cancer Network Registrars 56. Monti DA, Gomella L, Peterson E, Kunkel E. Preliminary Results from a novel
psychosocial program for men with prostate cancer. Abstract submitted ASCO 57. Fassan M, Wildemore B, Vecchione A, Morrione A, Gardiman M, McCue P, Palazzo J, Gomella L, Baffa R. Genetic and Expression Analyses of a Novel Tumor
Suppressor Gene, TS12Q, in Solid Tumors. Abstract submitted AACR 2007.
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
58. N. Fleshner, A. Finelli, A Evans, L.Gomella, M.S. Cookson, S. Taneja, M.S. Lucia,
M. Somerville, R. Rittmaster:The REDEEM Trial – A Placebo-Controlled Trial of Dutasteride in the Expectant Management of Men With Low-Grade Prostate Cancer Active Survillance, San Francisco January 12-13,2007 Publications
1. Hubosky, S and Gomella, LG Malignant Tumors of the Urogenital Tract in Conn’s
Current Therapy, Rakel, RE and Bope, ET (eds), Saunders, Philadelphia, PA, (2004Edition) 2. Brown, JA and Gomella, LG, Hand Assisted Laparoscopic Nephrectomy and
Nephroureterectomy, Glenn’s Operative Urology, Graham S (ed) 6th Edition LWW,Philadelphia , 2004) 3. Casale, P and Gomella, LG, Laparoscopic Pelvic Lymphadenectomy , Glenn’s
Operative Urology, Graham S (ed) 6th Edition LWW, Philadelphia , (2004) 4. Gomella, LG and Albala, DM: Basic Laparoscopy: Transperitoneal, Extraperitoneal
and Hand Assisted Techniques Glenn’s Operative Urology, Graham S (ed) 6thEdition LWW, Philadelphia (2004) 5. Razdan, S and Gomella LG Penile and Urethral Cancer in: Principles and Practice
Of Oncology, 7th Edition DeVita,V Hellman,S Rosenberg,S (Eds) (2004) 6. Letko,J and Gomella, LG Structural Renal Disorders in Aghababian et al: Essentials
of Emergency Medicine, LWW, Philadelphia (2004) 7. Perotti, M and Gomella, LG Treatment Decisions: Surgery Vs. Brachytherapy The
Urology Perspective in Dicker, A, Merrick, G, Waterman, F, Valicenti R and Gomella,
LG
(eds) Basic and Advanced Prostate Brachytherapy Taylor & Francis, Ltd. London
(2004)
8. Ramey, JR, Halpern, EJ, Gomella, LG Chapter 92: Ultrasonography and Biopsy of
the Prostate in Campbell Walsh Urology, 9th Edition Wein, AJ Editor (In Press 2006) 9. Ramey, JR, Gomella, LG Transrectal and Transperineal Ultrasound Guided Biopsy
of the Prostate in Prostate Cancer Principles and Practice Kirby, R, et al Eds. MartinDunitz, London (in Press 2006) 10. Gittens, P and Gomella, LG Enuresis in 5 Minute Clinical Consult, Dambro M
11. Nelson, E and Gomella, LG Testicular Cancer in 5 Minute Clinical Consult, Dambro
12. Nelson, E and Gomella, LG Polycystic Kidney Disease in 5 Minute Clinical Consult
13. Gomella, LG SCIENTIA: Update in the Treatment of Prostate Cancer, Vol IV, Issue
1, 2004 Rogers Medical Intelligence Solutions New York 14. Gomella LG, Dicker AP, Ferrari AC, Klein EA, Klotz L, Messing EM, Moul JW,
Roach M, See WA, Slovin SF, Taplin ME, Thompson IM. 2004 AUA Think TankProceedings, “Conversations with Urologic Oncology Leaders: Bridging the Gapbetween Research and Patient Care”, Prostate Cancer Update Series-Sept 2004,Vol. 3 (4) 2 Tapes / 2 CDs (Audio) 15. D'Amico AV, Gomella LG, Dreicer R. Conversations with Urologic Oncology
Leaders: Bridging the Gap between Research and Patient Care. Research toPractice, Prostate Cancer Update, Volume 4, Issue 2, May 2005. Monograph 16. Gomella, LG and Allen, F., "What's New on the Horizon, Treatment Choices for Men
Living with Advanced Prostate Cancer". Cancer Care Foundation, New York, July2005 Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
17. Kamat,AM, Cookson,MS, O’Donnell, MA, Gomella,LG, Bladder Cancer Options:
State-of-the-Art Patient Care Two Part Monograph PharmAdura, Orangeburg, NewYork (October/November 2005) 18. Gomella, LG, Lallas, C and Trabulsi E. Live webcast: Robotically Assisted Radical
Prostatectomy Thomas Jefferson University January 19, 2006 19. *Valicenti RK, Chervoneva I, Gomella LG. Importance of margin extent as a
predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostatecancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1093-7 20. *Brown JA, Garlitz C, Gomella LG, McGinnis DE, Diamond SM, Strup SE.
Perioperative morbidity of laparoscopic radical prostatectomy compared with openradical retropubic prostatectomy. Urol Oncol. 2004 Mar-Apr;22(2):102-6.
21. *Brown JA, Hubosky SG, Gomella LG, Strup SE. Hand assisted laparoscopic partial
nephrectomy for peripheral and central lesions: a review of 30 consecutive cases. JUrol. 2004 Apr;171(4):1443-6.
22. *O'Hara SM, Moreno JG, Zweitzig DR, Gross S, Gomella LG, Terstappen LW.
Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem. 2004 May;50(5):826-35. Epub 2004 Feb 26 23. * H.R. Lee, M.J. Solan, P.Lupinacci, L.G. Gomella, R.K. Vaicenti. Long-term
outcome of patients with prostate cancer and pathologic seminal vesicle invasion(pT3b): Effect of adjuvant radiotherapy. Urology 64 (1): 84-89, 2004 24. *Ives, EP, Burke, MA, Edmonds, PR, Gomella, LG, Halpern, EJ Quantitative CT
Perfusion of Prostate Cancer: Correlation with Whole Mount Pathology (In PressClinical Prostate Cancer, 2005) 25. Gomella, LG PCa prevention with 5-ARIs: What to tell patients Urology Times,
26. Gomella LG, When prostate cancer markers become unreliable: The PCPT
dilemma. Urol Oncol. 2004 May-Jun;22(3):260-1 27. *Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Long-term outcome of
patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effectof adjuvant radiotherapy. Urology. 2004 Jul;64(1):84-9.
28. *Vecchione A, Galetti TP, Gardiman M, Ishii H, Giarnieri E, Pagano F, Gomella
LG, Croce CM, Baffa R. Collecting duct carcinoma of the kidney: an
immunohistochemical study of 11cases. BMC Urol. 2004 Sep 09;4(1):11
29. *Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed
S, Somerville M, Rittmaster R; REDUCE Study Group. Chemoprevention of prostatecancer in men at high risk: rationale and design of the reduction by dutasteride ofprostate cancer events (REDUCE) trial. J Urol. 2004 Oct; 172(4 Pt 1):1314-7 30. *Vecchione A, Sevignani C, Giarnieri E, Zanesi N, Ishii H, Cesari R, Fong LY, Gomella LG, Croce CM, Baffa R. Inactivation of the FHIT gene favors bladder
cancer development. Clin Cancer Res. 2004 Nov 15;10(22):7607-12
31. Brown JA, Garlitz C, Strup SE, Hubosky SG, Gomella L. Laparoscopic radical
prostatectomy after neoadjuvant hormonal therapy: an apparently safe and effectiveprocedure. J Laparoendosc Adv Surg Tech A. 2004 Dec;14(6):335-8 32. *Trabulsi, EJ, Kalra, P, Gomella, LG New Approaches to the Minimally Invasive
Treatment of Kidney Tumors Cancer J. 2005 Jan-Feb;11(1):57-63. Review.
33. *Gomella LG, Is Interstitial Hyperthermia, a Safe and Efficacious Adjunct to
Radiotherapy for Localized Prostate Cancer? Practice Point Commentary: 2004 Dec;1(2)2-3.
34. *Gomella LG, Chemoprevention of Prostate Cancer using Dutasteride: the REDUCE
Trial. Review. Curr Opin Urol. 2005 Jan;15(1):29-32 Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
35. Gomella, L.G. “Addressing the Needs of the High-Risk Prostate Cancer Patient.”
Addressing the needs of the high-risk prostate cancer patient. Rev Urol. 2005;7Suppl 5:S18-28.
36. *Moreno JG, Miller MC, Gross S, Allard WJ, Gomella LG, Terstappen LW.
Circulating tumor cells predict survival in patients with metastatic prostate cancer.
Urology. 2005 Apr;65(4):713-8.
37. *Strup S, Garrett J, Gomella L, Rowland R. Laparoscopic partial nephrectomy:
hand-assisted technique. J Endourol. 2005 May;19(4):456-9; discussion 459-60.
38. *Gomella, LG. The Efficacy of Sildenafil Citrate Following Radiation Therapy for
Prostate Cancer: Temporal Considerations, Editorial Comment Ohebshalom et alEditorial Comment , J Of Urol July 2005 39. *Ives EP, Burke MA, Edmonds PR, Gomella LG, Halpern EJ. Quantitative computed
tomography perfusion of prostate cancer: correlation with whole-mount pathology.
Clin Prostate Cancer. 2005 Sep;4(2):109-12 40. *Ives EP, Gomella LG, Halpern EJ. Effect of Dutasteride Therapy on Doppler US
Evaluation of Prostate: Preliminary Results. Radiology. 2005 Oct;237(1):197-201 41. Gomella, LG Hormonal Therapy: New Uses for an Old Treatment, AUA News
42. *Brown JA, Strup SE, Chenven E, Bagley D, Gomella LG. Hand-assisted
laparoscopic nephroureterectomy: analysis of distal ureterectomy technique, marginstatus, and surgical outcomes. Urology. 2005 Dec;66(6):1192-6.
43. *Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG. Detection
of prostate carcinoma with contrast-enhanced sonography using intermittentharmonic imaging. Cancer. 2005 Dec 1;104(11):2373-83.
44. Kalra P, Glassman DT, Gomella LG, Strup SE, McGinnis DE, Simon DR, Chang
MF, Byrne DS, Kuo RL. Outcomes of hand-assisted laparoscopic nephrectomy intechnically challenging cases. Urology. 2006 Jan;67(1):45-9 45. Trabulsi, EJ, Merriam, W and Gomella, LG. New Imaging Techniques in Prostate
Cancer Curr Urol Rep. 2006 May;7(3):175-80 46. Gomella, L. Targeting the genetic basis of transitional cell carcinoma. (Editorial) J
47. Brown JA, Garlitz CJ, Hubosky SG, Gomella LG. Hand-assisted laparoscopic
ureterolysis to treat ureteral obstruction secondary to idiopathic retroperitonealfibrosis: assessment of a novel technique and initial series. Urology. 2006Jul;68(1):46-9. Epub 2006 Jun 27 ahead of print] 48. Monami,G ,Gonzalez, EM, Hellman, M, Gomella, LG, Baffa R, Iozzo, RV, Morrione
A. The Role of Proepithelin in Bladder Tumor Invasion. Cancer Res 2006; 66: (14).
July 15, 2006 49. Baffa R, Letko J, McClung C, Lenoir J, Vecchione A, Gomella, LG Molecular
Genetics Of Bladder Cancer: Targets For Diagnosis And Therapy J Exp Clin CancerRes. 2006 Jun;25(2):145-60) 50. Vecchione, A, Gottardo, F, Gomella, LG, Wildemore ,B, Fassan,M, Bragantini E, Pagano, F, Baffa, R. Molecular Genetics of Prostate Cancer: Clinical TranslationalOpportunities J. Exp. Clin. Cancer Res., 2007, 26, 1, 515-527 2007 51. Lawton, CA, DeSilvio, M, Lee, RW, Gomella, LG, Grignon,D, Gillin, M, Morton, G,
Pisansky, T, and Sandler, HS Results of a phase II trial of transrectal ultrasoundguided permanent radioactive implantation of the prostate for definitive managementof localized adenocarcinoma of the prostate (RTOG 98-05) (In Press IJROBP) 52. Abraham R, Pagano F, Gomella LG and Baffa R. Chromosomal Deletions In Bladder
Cancer: Shutting Down Pathways (in Press) Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
53. Gomella LG. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues. BJU Int. 2007 Jan;99 Suppl 1:25-9 54. Gomella LG. Global update on the use of hormonal therapy for the management of high-risk prostate cancer: Introduction. BJU Int. 2007 Jan;99 Suppl 1:1.
55. Gomella, LG Editorial Comment: Finasteride Improves the Sensitivity of Digital
Rectal Examination for Prostate Cancer Detection, Thompson, et al. (in Press J Urol2007) 56. Trabulsi, EJ and Diagnostic Imaging Approaches to Prostate Cancer (in Press US 57. Fradet Y , Grossman HB , Gomella, LG , Lerner, S, Cookson, M, Albala D, Droller MJ
A Comparison Of Hexaminolevulinate (HAL) Fluorescence Cystoscopy And WhiteLight Cystoscopy In The Detection Of Carcinoma In Situ In Patients With BladderCancer: A Phase III, Multicentre Study (In Press J Urol 2007) 58. Grossman HB, Gomella, LG, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo, U,
Droller MJ A Phase III, Multicentre Comparison Of Hexaminolevulinate (HAL)Fluorescence Cystoscopy And White Light Cystoscopy In The Detection OfSuperficial Papillary Lesions In Patients With Bladder Cancer (in Press J Urol 2007) 59. Gomella, LG Editorial Comment: Contrast Enhanced Color Doppler, Mitterberger, et
Costas Lallas, MD
1. Auge BK, Pietrow PK, Lallas CD, Raj G, Santa-Cruz R and Preminger GM. The ureteral access sheath provides protection against elevated renal pressuresgenerated during routine flexible ureteroscopic stone manipulation. Journal ofEndourology, 2004. February: 18(1):33-6.
2. Lallas CD, Preminger GM, Pearle MS, Leveillee RJ, Lingeman JE, Schwope JP, Pietrow PK and Auge BK. Internet-based multi-institutional clinical research: aconvenient and secure option. Journal of Urology, 2004. May: 171(5), 1880-5.
3. Lallas CD, Delvecchio FC, Evans B, Silverstein AS, Preminger GM, and Auge BK. Management of nephropleural fistula after supracostal percutaneousnephrolithotomy. Urology, 2004. October: 64(2), 241-5.
4. Parekattil SJ, Gill IS, Castle EP, Burgess SV, Walls MM, Thomas R, Kumar U, Purifoy JA, Ng CS, Kang Y, Fuchs GJ, Weise ES, Winfield HN, Lallas C,Andrews PE. Models to predict duration of stay after laparoscopic radical/simpleor partial nephrectomy: multi-institutional validation study. Journal of Urology,2005. October: 174 (4 Pt 1), 1380-4.
5. Lallas CD, Castle EP and Andrews PE. Hand port use for extraction during laparoscopic donor nephrectomy. Urology 2006 Apr;67(4):706-8. Epub 2006 Mar29.
6. Pais VM Jr, Lowe G, Lallas CD, Preminger GM, Assimos DG. Xanthine urolithiasis. Urology. 2006 May;67(5):1084.e9-11.
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
7. Wiygul JB, Lallas C, Silverstein A, Polascik TJ. Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman. Urology. 2006 May;67(5):1085.e5-6.
8. Lallas CD, Castle EP, Schlinkert RT and Andrews PE. The development of a laparoscopic donor nephrectomy program in a de novo transplant program:evolution of technique and results in over 200 cases. JSLS. 2006 Apr-Jun;10(2):135-40.
9. Daley SM, Lallas CD, Swanson SK, Novicki DE and Itano NB. Fibrin Sealant Closure of a Persistent Vesicovaginal Fistula after Failed TransabdominalClosure. Journal of Pelvic Medicine & Surgery, 12(4):229-230, July/August 2006.
10. Brisson T, Wehle M, Lallas CD, Castle EP, Igel TC, Petrou SP, Young PR and Andrews PE. Hand-assisted versus standard laparoscopic nephroureterectomy:is one preferable? Issues in Urology, 18(6): 255-258, November/December 2006.
Presentations and Abstracts
1. Lallas CD. Laparoscopic complications October, 2004 (Mazatlan, Mexico) Mayo 2. Lallas CD, Ferrigni RF and Andrews PE. Laparoscopic partial nephrectomy: Critical aspects November, 2004. Mayo Clinic Surgical Society meeting 3. Lallas CD. Post-operative follow-up strategies in genitourinary oncology November, 2004. Grand rounds, Mayo Clinic 4. Lallas CD and Andrews PE. Robotically-assisted laparoscopic prostatectomy: The Mayo Scottsdale technique February, 2005. Us, Too! Quarterly meeting,Phoenix, Arizona 5. Pak R, Wehle M, Andrews P, Lallas C, Young P and Igel T Laparoscopic Partial Nephrectomy: A comparison of two approaches March, 2005. SESAUA annualmeeting (Charleston, South Carolina) 6. Lallas CD, Castle EP, Schlinkert RT and Andrews PE. The development of a laparoscopic donor nephrectomy program in a de novo transplant program:Evolution of technique and results in over 200 cases May, 2005. Mayo ClinicAcademic Excellence Day July, 2005. WSAUA annual meeting (BritishColumbia, Canada) 7. Lallas CD, Andrews PE and Ferrigni RF. Robotically-assisted laparoscopic prostatectomy: The Mayo Scottsdale experience May, 2005. Mayo ClinicAcademic Excellence Day 8. Walls MM, Lallas CD, Castle EP, Andrews PE, Burgess SV, Thomas R.
Laparoscopic partial nephrectomy: Renal function evaluation of effect ofclamping versus non-clamping May, 2005. American Urological Associationannual meeting (San Antonio, TX) Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
9. Parekattil SJ, Castle EP, Lallas CD, Andrews PE and Gill IS. Models to predict duration of stay after laparoscopic radical/simple or partial nephrectomy: multi-institutional validation study. May, 2005. American Urological Association annualmeeting (San Antonio, TX) August, 2005. World Congress of Endourologyannual meeting (Amsterdam) 10. Linden RA, Thumar A, Haddad D, Dong SN, Gomella LG, Lallas CD and Trabulsi EJ. Addition of Robotic Surgery to an Established Laparoscopic ProstatectomyProgram: Initial Impact on Positive Surgical Margins.
11. December, 2006. Society of Urologic Oncology annual meeting (Bethesda): Poster February, 2007. American Society of Clinical Oncologists annual meeting(Orlando); May, 2007. American Urological Association annual meeting(Anaheim) 12. Yanke BV, Lallas CD, Hubosky SG, Linden RA and Bagley DH. Endoscopic Management of Upper Tract Transitional Cell Carcinoma. May, 2007. AmericanUrological Association annual meeting (Anaheim) 13. Yanke BV, Lallas CD, McGinnis D, Pagnani, C and Bagley DH. The Minimally Invasive Treatment of Ureteropelvic Junction Obstruction. May, 2007. AmericanUrological Association annual meeting (Anaheim) 14. Lallas CD, Andrews PE and Ferrigni RG. Robotically-assisted Laparoscopic Prostatectomy: The Mayo Scottsdale Technique. Video presented at theMexican Urologic Society annual meeting, 2005.
15. Lallas CD and Andrews PE. Technique of Laparoscopic Donor Nephrectomy.
Video presented at the Mayo Clinic Academic Excellence Day, 2005. Videopresented at the American College of Surgeons annual meeting, San Francisco,2005.
16. Lallas CD, Trabulsi EJ and Gomella LG. Robotically-assisted Laparoscopic Prostatectomy at Thomas Jefferson University Live Webcast, January 2006 Scott Hubosky, MD
1. Brown JA, Garlitz CJ, Strup SE, Hubosky SG, Gomella LG.: Laparoscopic radical prostatectomy after neoadjuvant hormonal therapy: An apparently safe andeffective procedure. Journal of Laparoendoscopic & Advanced SurgicalTechniques 14(6): 335-338, 2004.
2. McGinnis DE, Hubosky SG, Bergmann LS.: Hand-Assisted Laparoscopic Cystoprostatectomy and Urinary Diversion. Journal of Endourology 18: 383-386,2004.
3. Strup SE, Hubosky SG.: Hand-Assisted Laparoscopic Partial Nephrectomy.
Journal of Endourology 18: 345-351, 2004.
4. Brown JA, Hubosky SG, Gomella LG, Strup SE.: Hand-Assisted laparoscopic partial nephrectomy for peripheral and central lesions: A review of 30consecutive cases. Journal of Urology 171: 1443-1446, 2004 Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
5. Brown JA, Garlitz CJ, Hubosky SG, Gomella LG: Hand-assisted laparoscopic ureterolysis to treat ureteral obstruction secondary to idiopathic retroperitonealfibrosis: Assessment of a novel technique and initial series. Urology 68(1): 46-49,2006.
6. Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW: Single center experience with third generation cryosurgery for treatment oforgan confined prostate center: A critical evaluation of short term outcomes,complications and patient quality of life. Journal of Endourology 2006 7. Hubosky SG, Davis JW, Given RW, Fabrizio MD: Robotically assisted Laparoscopic Radical Prostatectomy (RaLRP) in a patient with ectopic ureteralinsertion into the prostate. Journal of Robotic Surgery 2006 (In press).
Edouard Trabulsi, MD
1. Touijer K, Kuroiwa K, Saranchuk JW, Hassen WA, Trabulsi EJ, Reuter VE, Guillonneau B. Quality improvement in laparoscopic radical prostatectomy forpT2 prostate cancer: impact of video documentation review on positive surgicalmargin.J Urol. 2005 Mar;173(3):765-8.
2. Trabulsi EJ, Guillonneau B. Laparoscopic radical prostatectomy. J Urol. 2005 3. Trabulsi EJ, Kalra P, Gomella LG. New approaches to the minimally invasive treatment of kidney tumors. Cancer J. 2005 Jan-Feb;11(1):57-63.
4. Trabulsi EJ, Merriam WG, Gomella LG. New imaging techniques in prostate cancer. Curr Urol Rep. 2006 May;7(3):175-80.
5. Trabulsi EJ, Valicenti RK. Dose escalation with proton-beam boost for low-risk prostate cancer. Nat Clin Pract Urol. 2006 May;3(5):256-7.
6. Valicenti, RK, Trabulsi, EJ, Hanlon, AL, Pisansky, TM, Sandler, HM, Kuban, DA,
Catton, C, Michalski, JM, Zelefsky, MJ, Kupelian, PA, Kestin, L, DeWeese, TL,Pollack, A. A Multi-Institutional Matched-Control Analysis of Adjuvant andSalvage Postoperative Radiation Therapy for pT3/4N0 Prostate Cancer. ASCOMeeting, February 24-26, 2006.
7. Trabulsi EJ, Valicenti RK. Dose escalation with proton-beam boost for low-risk prostate cancer. Nat Clin Pract Urol. 2006 May;3(5):256-257.
8. Trabulsi EJ, Merriam WG, Gomella LG. New imaging techniques in prostate
cancer. Curr Urol Rep. 2006 May;7(3):175-80.
9. Merriam, WG, Glassman, DT, Trabulsi, EJ, Gomella, LG. Risk od post-operative
rhabdomyolysis in patients undergoing laparoscopic nephrectomy. 101th AnnualAUA Scientific Meeting. J Urol. 175 (4): 343, April 2006.
10. Touijer K., Trabulsi E.J., Hassen W., and B. Guillonneau, “Laparoscopic Radical Prostatectomy: The Transperitoneal Antegrade Approach.” In LaparoscopicUrologic Surgery in Malignancies." JJMCH de la Rosette (Ed.) Springer-Verlag,2005.
Presentations and Abstracts
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
1. “Quality Improvement in Laparoscopic Radical Prostatectomy for pT2 Prostate Cancer: Impact of Video Documentation Review on Positive Surgical Margin.”Touijer KT, Kuroiwa K, Saranchuk J, Hassen W, Trabulsi EJ, Salamanca JM,Reuter VE, Guillonneau B. American Urologic Association Annual Meeting, SanAntonio TX, May 2005.
2. “Risk of Post-operative Rhabdomyolysis in Patients Undergoing Laparoscopic Nephrectomy.” Merriam WG, Glassman DT, Trabulsi EJ, Gomella LG. AmericanUrologic Association Annual Meeting, Atlanta GA, May 2006 3. “The Malignant Potential of Small Renal Masses.” Glassman DT, Sleeper JP, Byrne D, Trabulsi EJ, Gomella LG. American Urologic Association Mid-AtlanticSection Annual Meeting, Washington DC, Oct 2006 4. “Microflow Imaging of the Prostate during Contrast-enhanced Ultrasound: Initial Experience.” Halpern EJ, Forsberg F, Gittens PR, Trabulsi EJ, Gomella LG.
Radiological Society of North America Annual Meeting, Chicago IL, November
2006
5. “Samarium-153-Lexidronam Complex for Treatment of Occult Bony Metastasis in High-risk, Clinically Non-metastatic Prostate Cancer: A Phase 1 Trial.” Valicenti
RK, Trabulsi EJ, Intenzo C, Lavarino J, Dicker A, Xu Y, Chervoneva I. American
Society for Therapeutic Radiology and Oncology Annual Meeting, Philadelphia,
PA, November 2006
6. Prostate Cancer Update 2004.” E.J. Trabulsi American Cancer Society/Philadelphia Department of Public Health Continuing Medical EducationLecture, August 2004.
7. “Rising PSA after Prostate Cancer Treatment.” E.J. Trabulsi American Cancer Society 9th Annual Philadelphia Prostate Cancer Conference, November 2004.
8. “Erectile Dysfunction after Prostate Cancer Treatment.” E.J. Trabulsi Man-to-Man Prostate Cancer Support Group, Kimmel Cancer Center, Thomas JeffersonUniversity, March 2005.
9. “Point/Counterpoint: Neoadjuvant Chemotherapy is the Standard of Care for Muscle Invasive Bladder Cancer.” E.J. Trabulsi, S.B. Malkowicz, I Skinner
American Urologic Association Mid-Atlantic Section Annual Meeting, Phoenix AZ,
October 2005.
10. “A Multi-Institutional Matched-Control Analysis Of Adjuvant and Salvage Postoperative Radiation Therapy for pT3/4N0 Prostate Cancer.” RK Valicenti, EJTrabulsi, AL Hanlon, TM Pisansky, HM Sandler, DA Kuban, C Catton, JMMichalski, MJ Zelefsky, PA Kupelian, L Kestin, TL DeWeese, and A Pollack.
American Society of Clinical Oncology Prostate Cancer Symposium, SanFranciso, CA, February 2006.
11. “Surgical Therapy for Prostate Cancer.” E.J. Trabulsi Philadelphia College of Osteopathic Medicine, Department of Urology Grand Rounds, May 2006.
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
12. “Surgical Therapy for Prostate Cancer.” E.J. Trabulsi Thomas Jefferson University Hospital, Methodist Hospital Division, Department of Medicine GrandRounds, August 2006.
13. “Surgical Therapy for Prostate Cancer.” E.J. Trabulsi Kimmel Cancer Center Grand Rounds, Thomas Jefferson University, September 2006.
14. “ Superficial Bladder Cancer.” E.J. Trabulsi, Moderator American Urologic
Association Mid-Atlantic Section Annual Meeting, Washington, D.C., October,2006.
15. “Erectile Dysfunction after Treatment for Prostate Cancer.” E.J. Trabulsi Man-to- Man Prostate Cancer Support Group, Kimmel Cancer Center, Thomas JeffersonUniversity, November 2006.
16. Laparoscopic Radical Prostatectomy (Live Surgery) with DE McGinnis (Co-
Surgeon), Jefferson Medical College Department of Urology CentennialSymposium, Philadelphia, PA, October 2004.
17. Robotic-Assisted Laparoscopic Radical Prostatectomy, CME Live Webcast with
CD Lallas (Co-Surgeon), Thomas Jefferson University, Philadelphia, PA, January2006.
Richard Valicenti, MD
1. Michalski, J.,Winter, K., Roach, M., Markoe, A., Sandler, H., Ryu, J., Parliament, M., Purdy, J., Valicenti, R., Cox, J. Clinical outcome of patients treated with 3D
conformal radiation therapy 3D-CRT for prostate cancer on RTOG 9406,
Submitted to Int. J Radiat Oncol Biol Phys, February, 2007
2. Stephenson, A.J., Scardino, P.T., Kattan, M.W., Pisansky, T.J., Slawin, K.M, Klein, E.A., Anscher, M.S., Michalski, J.M., Sandler, H.M., Lin, D.W., Forman,
J.D., Zelefsky, M.J., Kestin, L.L., Roehrborn, C.G., Catton, C.N., DeWeese, T.L,
Liauw, S.L., Valicenti, R. K., Kuban, D.A., Pollack, A, Predicting the outcome of
salvage radiotherapy for recurrent prostate cancer after radical prostatectomy,
Accepted to JCO, February, 2007
3. Feng, M., Hanlon, A. L., Pisansky, T. M., Kuban, D.A, Catton, C., Michalski, J.
M, Zelefsky, M.J., Kupelian, P.A., Pollack, A, Kestin, L., Valicenti R.K.,
DeWeese, T.L., Sandler, H.M., Predictive factors for late genitourinary and
gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or
salvage radiotherapy, Accepted for publication in Int. J Radiat Oncol Biol Phys,
January 2007
4. Valicenti, R.K., Desilvio, M., Hanks, G.E., Porter, A., Brereton, H., Rosenthal,
S.A., Shipley, W.U., Sandler, H.M., Post treatment prostate-specific antigendoubling time as a surrogate endpoint for prostate cancer-specific survival: ananalysis of RTOG 92-02. , Int. J Radiat Oncol Biol Phys: 66(4): 1064-1071, 2006 Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
5. Roach, M., DeSilvio, M., Valicenti, R.K., Asbell, S.O., Lawton, C., Thomas, C.R,
Shipley, W. Whole-pelvic, “mini-pelvic” or prostate only external beamradiotherapy field following neoadjuvant and concurrent hormonal therapy inpatient treated on RTOG 94-13, Int. J Radiat Oncol Biol Phys. 66(3): 647-53,2006 6. Trabulsi, E., Valicenti, R.K., Dose escalation with proton-beam boost for low-risk
prostate cancer. Nature Clinical Practice Urology, 3 (5): 256-258, 2006 7. Wernicke, A. G., Valicenti, R.K., DiEva, K., Houser, C., Pequignot, E. Radiation
dose delivered to the proximal penis as a predictor of erectile dysfunction afterthree-dimensional conformal radiotherapy for localized prostate cancer. Int. J.
Radiat Oncol Biol Phys. 60(5): 1357-63, 2004 8. Febles, C. and Valicenti, R.K. Combining external beam radiation therapy with
prostate brachytherapy: issues and rationale. Basic and Advanced ProstateBrachytherapy, Urology 64 (5): 855-861, 2004 9. Bednarz, G., Michalski, D., Anne, P. R., Valicenti, R.K. Inverse treatment
planning using volume-based objective functions. Phys. Med. Biol. 49(12): 2503-14, 2004 10. Lee, H, Solan, M., Hyslop, T, Gomella, L, Valicenti, R. Long-term outcome of
prostate cancer patients with pathological seminal vesicle invasion (pT3b): theeffect of early adjuvant radiation therapy. Urology. 64(1):84-89, 2004 11. Valicenti, R.K., Chervonva, I., Gomella, L.G. The importance of margin extent as
a predictor of outcome after adjuvant radiation therapy for Gleason score 7pT3N0 prostate cancer. Int. J Radiat Oncol Biol Phys. 58(4): 1093-97, 2004 12. Michalski, J., Winter, K., Perez, C., Ryu, J., Parliament, M., Valicenti, R., Roach,
M., Sandler, H., Markoe, A., Cox, J. Toxicity following 3D radiation therapy forprostate cancer on RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys.
58(3): 735-42, 2004 13. Valicenti, R.K., Dicker, A.P., Jaffray, D.A., Editors for textbook: Prostate Cancer:
Principles and Practices of Image-Guided Radiation Therapy, InformaHealthcare, Inc., to be published in 2008 14. Pisansky, T.M., Pollack, A., Sandler, H.M., Valicenti, R.K., Letter to the Editor,
15. Zelefsky, M., Valicenti, R.K, Perez, C. Low risk prostate cancer. Principles and
Practice of Radiation Oncology, 5th edition, J.P. Lippincott Company, to bepublished in 2007 16. Trabulsi, E., Valicenti, R.K., Radiation therapy and urology: State of the art
17. Valicenti, R.K. The Andrews/Roach Article Reviewed, Oncology, Clinical
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
18. Dicker, A., Merrick, G., Gomella, L., Waterman, F., Valicenti, R. Editors for
textbook: Basic and Advanced Prostate Brachytherapy, Martin Dunitz Limited,2005 19. Dicker, A., Chen, C., Liu, J., Valicenti, R., Waterman, F. The impact of hormonal
therapy on pubic arch interference. Basic and Advanced Prostate Brachytherapy,Martin Dunitz Limited, 2005 20. Febles, C. and Valicenti, R.K. Using external beam radiation therapy with
prostate brachytherapy. Basic and Advanced Prostate Brachytherapy, MartinDunitz Limited, 2005 21. McAleer, M. and Valicenti, R.K. Regionally advanced adenocarcinoma of the
Prostate: management and prognosis, Urologic Oncology, W.B. Saunders, 2004 22. Zeltser, I., Valicenti, R.K., Gomella L.G. Management of PSA recurrence after
definitive therapy for prostate cancer in Management of Prostate Cancer.
Humana Press, 2004 Presentations and Abstracts
1. Valicenti R., Trabulsi, E. Intenzo, C., Lavarino, J., Xu, Y., Chervoneva, I., A
phase I trial of samarium-153 –lexidronam with hormonal therapy and radiation
therapy for high-risk, clinically non-metastatic prostate cancer, Poster
presentation , ASTRO, Philadelphia, PA, November, 2006
2. Valicenti, R.K., Desilvio, M., Hanks, G.E., Porter, A., Brereton, H., Rosenthal,
S.A., Shipley, W.U., Sandler, H.M., Post treatment prostate-specific antigen
doubling time as a surrogate endpoint for prostate cancer-specific survival: an
analysis of RTOG 92-02, Oral presentation ,ASCO Prostate Cancer Symposium,
San Francisco, CA, February, 2006
3. Valicenti R.K., Hanlon, A. L., Pisansky, T. M., Sandler, H.M., Kuban, D.A,
Catton, C., Michalski, J. M, Zelefsky, M.J., Kupelian, P.A., Kestin, L., DeWeese,
T.L. Pollack, A, A multi-institutional matched-control analysis of adjuvant and
salvage postoperative radiotherapy for pT3/4N0 prostate cancer, Oral
presentation, ASCO Prostate Cancer Symposium, San Francisco, CA, February,
2006
4. Valicenti R.K., Hanlon, A. L., Pisansky, T. M., Sandler, H.M., Kuban, D.A,
Catton, C., Michalski, J. M, Zelefsky, M.J., Kupelian, P.A., Kestin, L., DeWeese,
T.L. Pollack, A, A multi-institutional matched-control analysis of adjuvant and
salvage postoperative radiotherapy for pT3/4N0 prostate cancer, Oral
presentation, ASTRO, Denver, CO, October, 2005
5. Valicenti, R., Desilvio, M., Hanks, G., Porter, M., Brereton, H., Shipley, W.,
Sandler, H., Surrogate endpoint for prostate cancer-specific survival: validation
from an analysis of RTOG 92-02. Poster discussion presentation, ASCO,
Orlando, FL, May 15, 2005
Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
6. GU Discussant for Late Toxicities, RTOG Scientific Session, Tampa, FL, 7. Cone beam in prostate radiation therapy, Session Chair, Elekta Research Group Annual Meeting, Nice, France, January 20, 2007 8. Cone beam in post-prostatectomy radiation therapy, Session Chair, Elekta Research Group Annual Meeting, Lecture, Nice, France, January 20, 2007 9. Cone beam in the post-prostatectomy setting, Elekta Research Group Annual 10. New approaches to manage subclinical bony metastases in high-risk prostate cancer, Lecture, Nashville, TN, September 26, 2006 11. Predictors of metastatic prostate cancer: role of PSA-DT, Medical Grand Rounds, Methodist Hospital, Philadelphia, PA, September 6, 2006 12. PSA-DT as a surrogate biomarker for prostate clinical trials, New Orleans, LA, 13. The role of cone-beam image guidance in post-prostatectomy radiation therapy, Annual Elekta Image Guidance Consortium Meeting, Miami, Fl, January 6, 2006 14. Predictors of prostate cancer-specific mortality, Winston Salem, NC, December 15. The role of adjuvant treatment in prostate cancer, Medical Grand Rounds, Fairfax Healthcare System, Fairfax, Val, November 16, 2005 16. Adjuvant radiation therapy after radical prostatectomy-is it time for a new standard of care? Plenary Discussant, ASTRO Annual Meeting, October 17,2005 17. NOCR, Challenging Cases in Prostate Cancer, Faculty, Chicago, IL, October 1, 18. Prostate Cancer End-Point Meeting, Prostate Cancer Foundation, New York, NY, 19. NOCR, Challenging Cases in Prostate Cancer, Faculty, Las Vegas, NV, June 4, 20. Emerging therapies for localized prostate cancer, Panama City, FL, May 11, 21. Oncology Grand Rounds, Discussant, Panama City, FL, May 11, 200522. Combining hormonal therapy and radiation therapy for prostate cancer, 23. Emerging therapies for prostate cancer, Oncology Grand Rounds, Morristown General Hospital, Morristown, NJ, April 27, 2005 24. Sexual dysfunction after prostate cancer treatment, Philadelphia, PA, March 17, Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
25. Surrogate endpoint for prostate cancer mortality or rationale for new treatment development, 1st Annual Prostate Cancer Symposium, Cancer Centers of theCarolinas, Greenville, SC, February, 12, 2005 26. A definition of biochemical failure after combined androgen deprivation and radiation therapy, RTOG PSA Consensus Symposium, Phoenix, AZ, January 21,2005 27. NOCR, Challenging Cases in Prostate Cancer, Faculty, Las Vegas, NV, October 28. New developments in combining hormonal therapy and radiation therapy in prostate cancer, Grand Rounds, Department of Radiation Oncology, St.
Barnabas Hospital, NJ, October 13, 2004 29. New developments in prostate cancer radiation therapy, Moffitt Cancer Center 1st Annual Prostate Cancer Meeting, Orlando, FL, October 8, 2004 30. Prostate Cancer Session, Program Moderator, ASTRO, Atlanta, GA, October 6, 31. The management of symptomatic bone metastases, Society of Nuclear Medicine Annual Meeting, Philadelphia, PA, June 20, 2004 32. Bone-targeted therapy for metastatic cancer, Dattoli Prostate Cancer Institute, 33. NOCR, Challenging Cases in Prostate Cancer, Faculty, Chicago, IL, June 12, 34. Visiting Professor, Department of Radiation Oncology, Wayne State University 35. NOCR, Challenging Cases in Prostate Cancer, Faculty, Miami, Fl, April 3, 2004 36. NOCR, Challenging Cases in Prostate Cancer, Faculty, New York, NY, February 37. Post-prostatectomy radiation therapy, Resident Didactic Lecture, Department of Radiation Oncology, Thomas Jefferson University, May, 2006 38. Dose response relationship in the prostate cancer, Resident Didactic Lecture, Department of Radiation Oncology, Thomas Jefferson University, March, 2006 39. The use of hormonal therapy in the treatment of prostate cancer, Resident Didactic Lecture, Department of Radiation Oncology, Thomas JeffersonUniversity, February, 2006 40. A year in review in prostate cancer research, 2005 ASTRO Update, November 41. Research to Private Practice, Resident Seminar, Department of Radiation Oncology, Thomas Jefferson University, June 30, 2005 Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
42. Post-operative radiation therapy for prostate cancer, Resident Seminar, Department of Radiation Oncology, Thomas Jefferson University, April 21, 2005 43. How to decide on treatment for prostate cancer, Man-to-Man, Kimmel Cancer 44. Radiation therapy dose escalation for prostate cancer, Resident Seminar, Department of Radiation Oncology, Thomas Jefferson University, March 25,2005 45. PSA doubling time as a surrogate endpoint for prostate cancer clinical trials, Kimmel Cancer Center Grand Rounds, Philadelphia, PA, February 16, 2005 46. New developments in combining hormonal therapy and radiation therapy for prostate cancer, Kimmel Cancer Center Prostate Cancer Symposium,Philadelphia, PA, December 1, 2004 47. Review of ASTRO 2004 Annual Meeting, Jefferson Oncology Network, 48. Valicenti R., Trabulsi, E. Intenzo, C., Dicker, A., Lavarino, J., Xu, Y.,
Chervoneva, I., A phase I trial of samarium-153 –lexidronam with hormonaltherapy and radiation therapy for high-risk, clinically non-metastatic prostatecancer, ASTRO, Philadelphia, PA, November, 2006 49. Showalter, T.N., Nawaz, A. O., Xiao, Y., Galvin, J.,M., Valicenti R.K., A cone
beam CT-based study of interfraction movement of the rectum and bladderduring radiation therapy in post-prostatectomy patients, ASTRO, Philadelphia,PA, November, 2006 50. Valicenti R.K., Hanlon, A. L., Pisansky, T. M., Sandler, H.M., Kuban, D.A,
Catton, C., Michalski, J. M, Zelefsky, M.J., Kupelian, P.A., Kestin, L., DeWeese,T.L. Pollack, A, A multi-institutional matched-control analysis of adjuvant andsalvage postoperative radiotherapy for pT3/4N0 prostate cancer, ASTRO,Denver, CO, October, 2005 51. Lawton, C., DeSilvio, M., Roach, M., Uhl, V., Seider, M., Krisch, R. Rotman, M.,
Jones, C., Asbell, S., Valicenti, R.K., Han, S., Thomas, C.R. An update of the
phase III trial comparing whole-pelvic to prostate only radiotherapy and
neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG
94-13, ASTRO, Denver, CO, October, 2005
52. Pollack, A, Hanlon, A. L., Pisansky, T. M., Sandler, H.M., Kuban, D.A, Catton, C., Michalski, J. M, Zelefsky, M.J., Kupelian, P.A., Kestin, L., Valicenti R.K,
DeWeese, T.L. Which definition of biochemical failure after post-operative
radiotherapy predicts best for clinical failure? a multi-institutional analysis, AUA,
San Antonio, TX, May, 2005
53. Valicenti, R., Desilvio, M., Hanks, G., Porter, M., Brereton, H., Shipley, W.,
Sandler, H., Surrogate endpoint for prostate cancer-specific survival: validationfrom an analysis of RTOG 92-02, ASCO, Orlando, FL, May, 2005 Recent Publications and Presentations by Members of The GU
Multidisciplinary Cancer Clinic, Kimmel Cancer Center, Philadelphia, PA
54. Roach, M., DeSilvio, M., Thomas, C.R., Valicenti, R.K., Asbell, S.O., Lawton,
C., Shipley, W. Progression free survival (PFS) after whole-pelvic (WP) vs “Mini-Pelvic” (MP) or prostate only (PO) radiotherapy (RT): A subset analysis ofRTOG 9413, a Phase III prospective randomized trial using neoadjuvant andconcurrent (N&CHT), ASTRO, Atlanta, GA, October, 2004 55. Michalski, J.,Winter, K., Roach, M., Markoe, A., Sandler, H., Ryu, J., Parliament, M.,Purdy, J., Valicenti, R., Cox, J. Clinical outcome of patients treated with 3D
conformal radiation therapy 3D-CRT for prostate cancer on RTOG 9406,
ASTRO, Atlanta, GA, October, 2004

Source: http://www.kimmelcancercenter.org/kcc/kccnew/clinicalcare/urologiccancer/pubs-2004-2006.pdf

parkinsonsclinic.com

Activa® Deep Brain Stimulation (DBS) is a treatment for Parkinson’s disease that can improve some of the symptoms of Parkinson’s disease. Take this simple quiz to better understand if you might be a candidate for Activa DBS. Directions: Answer the following questions and consider the recommendations at the bottom of this quiz. 1) Do you experience troubling “off” periods (perio

Personality disorders have a lack of individual accountability results in a victim mentality and blaming others, society and t

Psychiatry Board Handouts Panic disorders : Panic disorder is characterized by the spontaneous and unexpected occurrence of panic attacks , the frequency of which can vary from several attacks a day to only a few attacks a year. Patients present with palpitations, pounding heart, accelerated heart rate sweating trembling or shaking sense of shortness of breath or smothering feeling of

Copyright © 2010-2014 Drugstore Pdf Search